Newsbenzinga
Wegovy for Overweight Young Children: Novo Nordisk’s Obesity Drug Shows Effectiveness
· Published
Article summary
Novo Nordisk Phase 3 STEP Young trial shows once-weekly semaglutide reduced BMI in 40.4% of children with obesity after 68 weeks.
An excerpt from the original article.
Comments —
Loading comments…